Infinity Pharmaceuticals Inc INFI:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/16/22 EDT
0.5586quote price arrow up+0.0213 (+3.96%)
Volume
428,807
52 week range
0.46 - 3.89
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.5586
  • 52 Week High3.89
  • 52 Week High Date09/02/21
  • 52 Week Low0.46
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap49.80M
  • Shares Out89.16M
  • 10 Day Average Volume0.98M
  • Dividend-
  • Dividend Yield-
  • Beta2.23
  • YTD % Change-75.17

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.5586
  • 52 Week High3.89
  • 52 Week High Date09/02/21
  • 52 Week Low0.46
  • 52 Week Low Date05/12/22
  • Market Cap49.80M
  • Shares Out89.16M
  • 10 Day Average Volume0.98M
  • Dividend-
  • Dividend Yield-
  • Beta2.23
  • YTD % Change-75.17

RATIOS/PROFITABILITY

  • EPS (TTM)-0.52
  • P/E (TTM)-1.08
  • Fwd P/E (NTM)-0.96
  • EBITDA (TTM)-45.426M
  • ROE (TTM)-148.54%
  • Revenue (TTM)2.04M
  • Gross Margin (TTM)39.75%
  • Net Margin (TTM)-2,254.97%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date07/25/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Infinity Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Infinity Pharmaceuticals, Inc. clinical-stage biopharmaceutical company that is focused on developing medicines for people with cancer. The Company is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma (PI3K-gamma). Its eganelisib clinical development program includes MAcrophage Reprogramming in...
Adelene Perkins
Chairman of the Board, Chief Executive Officer
Lawrence Bloch Jr., M.D.
President, Treasurer
Address
1100 Massachusetts Ave Ste 4
Cambridge, MA
02138-5241
United States

Top Peers

SYMBOLLASTCHG%CHG
SCYX
SCYNEXIS Inc
2.09+0.02+0.97%
SEEL
Seelos Therapeutics Inc
0.5562-0.0073-1.2955%
ZYNE
Zynerba Pharmaceuticals Inc
0.93+0.0743+8.68%
TRVN
Trevena Inc
0.3028+0.0998+49.16%
GTBP
GT Biopharma Inc
2.06+0.13+6.74%